Fox RJ, Cohan S, Mao-Draayer Y, Weinstock-Guttman B, et al. Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study. Mult Scler 2025;31:706-718.
PMID: 40248858